Alexza launches ADASUVE in the Nordic Countries
Grupo Ferrer Internacional (Ferrer) is commercializing ADASUVE in the Nordic countries via a distribution agreement with Medivir. Ferrer is Alexza’s commercial partner for ADASUVE in the Europe, Latin
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases.
Umeclidinium is a once-daily long-acting muscarinic antagonist (LAMA), a type of bronchodilator also known as an anticholinergic. According to the company, Incruse contains 62.5mcg umeclidinium and is delivered